Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: J Drug Issues. 2010 Dec;40(1):155–172. doi: 10.1177/002204261004000109

Table 1.

Comparison of Conventional GCM and Alternative GCM for the MPP Randomized Prevention Intervention Trial

Cigarette
Alcohol
Marijuana
Model A1 Model B1 Model A Model B Model A Model B
Intercept
 Mean 11.486 (1.231)** 15.001 (1.536)** 2.965 (.499)** 7.344 (1.024)** 1.960 (.365)** 4.498 (.750)**
 PROGRAM −.631 (2.173) −3.729(2.134) −.719 (.942) −3.109 (1.877) −1.012 (.689) −2.258 (1.370)
 PUBLIC 7.856 (2.182)** 3.989 (2.143) 2.030 (.946)* .665 (1.885) 1.238 (.692) 3.075 (1.375)*
 Baseline as a covariate N/A .888 (.133)* N/A .651 (.274)* N/A .295 (.268)
Slope
 Mean 2.370 (.212)** 2.060 (.315)** 3.250 (.196)** 2.962 (.223)** 1.404 (.165)** 1.122 (.192)**
 PROGRAM −.470 (.369) .177 (.555) −.582 (.372) −.086 (.431) −.415 (.312) −.012 (.328)
 PUBLIC −1.338 (.371)** −1.822 (.558)** −.562 (.373) −.519 (.432) .576 (.314 ) .021 (.329)
 Baseline as a covariate N/A −.055 (.035) N/A −.072 (.063) N/A .266 (.064)**
Model fit
Chi-square 30.966 19.064 43.764 21.443 54.171 19.669
df 17 14 17 14 17 14
P-value 0.020 0.163 0.001 0.091 0.001 0.141
CFI 0.891 0.948 0.500 0.956 0.745 0.944
RMSEA 0.142 0.106 0.175 0.056 0.223 0.113

Notes. 1. Model A: GCM with baseline as the initial status; Model B: GCM with baseline as a time-invariant covariate.

**

significant at .01;

*

significant at 0.05;

significant at 0.10.